[Therapeutic effect of blood viscosity in stroke].
D000721:Ancrod / Q000627:therapeutic use; D001798:Blood Proteins; D001809:Blood Viscosity / Q000187:drug effects*; D001815:Bloodletting; D002561:Cerebrovascular Disorders / Q000503:physiopathology*; D003911:Dextrans / Q000627:therapeutic use; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006400:Hematocrit; D006801:Humans; D010958:Plasminogen / Q000032:analysis
D001798:Blood Proteins; D003911:Dextrans; D005338:Fibrin Fibrinogen Degradation Products; D010958:Plasminogen; D000721:Ancrod
Therapeutische Beeinflussung der Blut-Viskosität beim Schlaganfall.